A critical analysis of the role of testosterone in erectile function: From pathophysiology to treatment - A systematic review

European Urology

Volumn 65, Issue 1, 2014, Pages 99-112

  Isidori, Andrea M ^a   Buvat, Jacques ^b   Corona, Giovanni ^c   Goldstein, Irwin ^d   Jannini, Emmanule A ^e   Lenzi, Andrea ^a   Porst, Hartmut ^f   Salonia, Andrea ^g   Traish, Abdulmaged M ^h   Maggi, Mario ⁱ  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Centre ETPARP   (France)

^c BELLARIA HOSPITAL   (Italy)

^d ALVARADO HOSPITAL   (United States)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f Private Practice of Urology and Andrology   (Germany)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5 reductase inhibitors; Aging; Erectile dysfunction; Hypogonadism; PDE5; Sexual function

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; PHOSPHODIESTERASE V INHIBITOR; PROPIONIC ACID; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; UNDECANOIC ACID;

ANDROGEN THERAPY; DIFFERENTIAL DIAGNOSIS; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; MALE; MALE FERTILITY; MEDICAL RECORD REVIEW; NONHUMAN; PATHOPHYSIOLOGY; PENIS ERECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; ALGORITHM; PHYSIOLOGY;

ALGORITHMS; ERECTILE DYSFUNCTION; HUMANS; MALE; PENILE ERECTION; PHOSPHODIESTERASE 5 INHIBITORS; TESTOSTERONE;

EID: 84888835369     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.08.048     Document Type: Review

References (81)

1. A. Salonia, G. Castagna, and A. Sacca Is erectile dysfunction a reliable proxy of general male health status? The case for the international index of erectile function-erectile function domain J Sex Med 9 2012 2708 2715
2. S.A. Hall, R. Shackelton, R.C. Rosen, and A.B. Araujo Sexual activity, erectile dysfunction, and incident cardiovascular events Am J Cardiol 105 2010 192 197
3. F. Montorsi, A. Briganti, and A. Salonia Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease Eur Urol 44 2003 360 364
4. F.C. Wu, A. Tajar, and J.M. Beynon Identification of late-onset hypogonadism in middle-aged and elderly men N Engl J Med 363 2010 123 135
5. G. Corona, G. Rastrelli, and M. Monami Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study Eur J Endocrinol 165 2011 687 701
6. A. Nicolosi, J. Buvat, D.B. Glasser, U. Hartmann, E.O. Laumann, and C. Gingell Sexual behaviour, sexual dysfunctions and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors World J Urol 24 2006 423 428
7. A. Salonia, M. Ferrari, and A. Sacca Delay in seeking medical help in patients with new-onset erectile dysfunction remained high over and despite the PDE5 era - an ecological study J Sex Med 9 2012 3239 3246
8. A. Tsertsvadze, H.A. Fink, and F. Yazdi Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis Ann Intern Med 151 2009 650 661
9. T.S. Kohler, J. Kim, and K. Feia Prevalence of androgen deficiency in men with erectile dysfunction Urology 71 2008 693 697
10. C. Wang, E. Nieschlag, and R. Swerdloff Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations J Androl 30 2009 1 9
11. J. Buvat, M. Maggi, and L. Gooren Endocrine aspects of male sexual dysfunctions J Sex Med 7 2010 1627 1656
12. K. Hatzimouratidis, E. Amar, and I. Eardley Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation Eur Urol 57 2010 804 814
13. E. Giannetta, D. Gianfrilli, F. Barbagallo, A.M. Isidori, and A. Lenzi Subclinical male hypogonadism Best Pract Res Clin Endocrinol Metab 26 2012 539 550
14. A. Tajar, G. Forti, and T.W. O'Neill Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study J Clin Endocrinol Metab 95 2010 1810 1818
15. A.F. Radicioni, E. De Marco, and D. Gianfrilli Strategies and advantages of early diagnosis in Klinefelter's syndrome Mol Hum Reprod 16 2010 434 440
16. S. Filippi, L. Vignozzi, and A. Morelli Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome J Sex Med 6 2009 3274 3288
17. E.M. Hull, D.S. Lorrain, and J. Du Hormone-neurotransmitter interactions in the control of sexual behavior Behav Brain Res 105 1999 105 116
18. T.M. Mills, R.W. Lewis, and V.S. Stopper Androgenic maintenance of inflow and veno-occlusion during erection in the rat Biol Reprod 59 1998 1413 1418
19. J. Lugg, C. Ng, J. Rajfer, and N. Gonzalez-Cadavid Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity Am J Physiol 271 1996 E354 E361
20. F. Giuliano, O. Rampin, A. Schirar, A. Jardin, and J.P. Rousseau Autonomic control of penile erection: modulation by testosterone in the rat J Neuroendocrinol 5 1993 677 683
21. A.M. Traish, K. Park, V. Dhir, N.N. Kim, R.B. Moreland, and I. Goldstein Effects of castration and androgen replacement on erectile function in a rabbit model Endocrinology 140 1999 1861 1868
22. C.M. Reilly, R.W. Lewis, V.S. Stopper, and T.M. Mills Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway J Androl 18 1997 588 594
23. C.M. Reilly, V.S. Stopper, and T.M. Mills Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum J Androl 18 1997 26 31
24. A. Morelli, S. Filippi, and R. Mancina Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa Endocrinology 145 2004 2253 2263
25. X.H. Zhang, A. Morelli, and M. Luconi Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum Eur Urol 47 2005 409 416
26. R. Yang, Y.C. Huang, and G. Lin Lack of direct androgen regulation of PDE5 expression Biochem Biophys Res Commun 380 2009 758 762
27. S.A. Andric, M.M. Janjic, N.J. Stojkov, and T.S. Kostic Testosterone-induced modulation of nitric oxide-cGMP signaling pathway and androgenesis in the rat Leydig cells Biol Reprod 83 2010 434 442
28. A. Morelli, P. Comeglio, and S. Filippi Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit Prostate 73 2013 428 441
29. A.M. Traish, P. Toselli, S.J. Jeong, and N.N. Kim Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency J Androl 26 2005 242 248
30. L.S. Baskin, R.S. Sutherland, M.J. DiSandro, S.W. Hayward, J. Lipschutz, and G.R. Cunha The effect of testosterone on androgen receptors and human penile growth J Urol 158 1997 1113 1118
31. M. Boas, K.A. Boisen, and H.E. Virtanen Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys Eur J Endocrinol 154 2006 125 129
32. A.M. Traish, J. Hassani, A.T. Guay, M. Zitzmann, and M.L. Hansen Adverse side effects of 5alpha-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients J Sex Med 8 2011 872 884
33. M.R. Pinsky, S. Gur, A.J. Tracey, A. Harbin, and W.J. Hellstrom The effects of chronic 5-alpha-reductase inhibitor (dutasteride) treatment on rat erectile function J Sex Med 8 2011 3066 3074
34. P.Y. Liu, K. Erkkila, and Y. Lue Genetic, hormonal, and metabolomic influences on social behavior and sex preference of XXY mice Am J Physiol Endocrinol Metab 299 2010 E446 E455
35. I.L. Ward, A.L. Bennett, O.B. Ward, S.E. Hendricks, and J.A. French Androgen threshold to activate copulation differs in male rats prenatally exposed to alcohol, stress, or both factors Horm Behav 36 1999 129 140
36. G. Corona, E. Mannucci, and V. Ricca The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction Int J Androl 32 2009 720 728
37. M. Kwan, W.J. Greenleaf, J. Mann, L. Crapo, and J.M. Davidson The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men J Clin Endocrinol Metab 57 1983 557 562
38. E.L. Rhoden, C. Teloken, P.R. Sogari, and C.A. Souto The relationship of serum testosterone to erectile function in normal aging men J Urol 167 2002 1745 1748
39. D.B. O'Connor, D.M. Lee, and G. Corona The relationships between sex hormones and sexual function in middle-aged and older European men J Clin Endocrinol Metab 96 2011 E1577 E1587
40. P.B. Gray, A.B. Singh, and L.J. Woodhouse Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men J Clin Endocrinol Metab 90 2005 3838 3846
41. F. Buena, R.S. Swerdloff, and B.S. Steiner Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range Fertil Steril 59 1993 1118 1123
42. M.M. Basar, G. Aydin, and H.C. Mert Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function Urology 66 2005 597 601
43. J. Bancroft, and F.C. Wu Changes in erectile responsiveness during androgen replacement therapy Arch Sex Behav 12 1983 59 66
44. C. Wang, G. Cunningham, and A. Dobs Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men J Clin Endocrinol Metab 89 2004 2085 2098
45. E.J. Giltay, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, F. Saad, and S.Y. Kalinchenko Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome J Sex Med 7 2010 2572 2582
46. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes J Sex Med 10 2013 1612 1627
47. M. Zitzmann, A. Mattern, J. Hanisch, L. Gooren, H. Jones, and M. Maggi IPASS: A study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men J Sex Med 10 2013 579 588
48. A.M. Isidori, E. Giannetta, and D. Gianfrilli Effects of testosterone on sexual function in men: results of a meta-analysis Clin Endocrinol (Oxf) 63 2005 381 394
49. E.R. Bolona, M.V. Uraga, and R.M. Haddad Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 2007 20 28
50. G. Cavallini, S. Caracciolo, G. Vitali, F. Modenini, and G. Biagiotti Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging Urology 63 2004 641 646
51. H.S. Chiang, T.I. Hwang, and Y.S. Hsui Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function Int J Impot Res 19 2007 411 417
52. H.S. Chiang, S.L. Cho, Y.C. Lin, and T.I. Hwang Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score Urology 73 2009 762 766
53. A.D. Seftel, R.J. Mack, A.R. Secrest, and T.M. Smith Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning J Androl 25 2004 963 972
54. F. Saad, A. Aversa, A.M. Isidori, L. Zafalon, M. Zitzmann, and L. Gooren Onset of effects of testosterone treatment and time span until maximum effects are achieved Eur J Endocrinol 165 2011 675 685
55. J. Buvat, A. Lemaire, and M. Buvat-Herbaut Human chorionic gonadotropin treatment of nonorganic erectile failure and lack of sexual desire: a double-blind study Urology 30 1987 216 219
56. A.T. Guay, S. Bansal, and G.J. Heatley Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate J Clin Endocrinol Metab 80 1995 3546 3552
57. D.J. Moskovic, D.J. Katz, A. Akhavan, K. Park, and J.P. Mulhall Clomiphene citrate is safe and effective for long-term management of hypogonadism BJU Int 110 2012 1524 1528
58. T.C. Hsieh, A.W. Pastuszak, K. Hwang, and L.I. Lipshultz Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy J Urol 189 2013 647 650
59. E.A. Jannini, E. Screponi, and E. Carosa Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone Int J Androl 22 1999 385 392
60. E.A. Jannini, A.M. Isidori, and G.L. Gravina The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction J Sex Med 6 2009 2547 2560
61. M. Spitzer, S. Basaria, and T.G. Travison Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial Ann Intern Med 157 2012 681 691
62. A. Aversa, R. Bruzziches, and D. Francomano Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 2010 3495 3503
63. G. Corona, E.A. Jannini, and F. Lotti Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu Int J Androl 34 2011 41 48
64. R. Shamloul, H. Ghanem, and I. Fahmy Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study J Sex Med 2 2005 559 564
65. J. Buvat, F. Montorsi, and M. Maggi Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) J Sex Med 8 2011 284 293
66. G. Corona, and M. Maggi The role of testosterone in erectile dysfunction Nat Rev Urol 7 2010 46 56
67. A. Fabbri, E. Giannetta, A. Lenzi, and A.M. Isidori Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available Expert Opin Biol Ther 7 2007 1093 1106
68. M. Zitzmann Pharmacogenetics of testosterone replacement therapy Pharmacogenomics 10 2009 1341 1349
69. A. Morgentaler, and A.M. Traish Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth Eur Urol 55 2009 310 320
70. A.W. Roddam, N.E. Allen, P. Appleby, and T.J. Key Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies J Natl Cancer Inst 100 2008 170 183
71. M. Gacci, G. Corona, and M. Salvi A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia Eur Urol 61 2012 994 1003
72. S. Basaria, A.D. Coviello, and T.G. Travison Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
73. M.M. Fernandez-Balsells, M.H. Murad, and M. Lane Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 2010 2560 2575
74. R.M. Haddad, C.C. Kennedy, and S.M. Caples Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 2007 29 39
75. L. Xu, G. Freeman, B.J. Cowling, and C.M. Schooling Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials BMC Med 11 2013 108
76. A. Mathur, C. Malkin, B. Saeed, R. Muthusamy, T.H. Jones, and K. Channer Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men Eur J Endocrinol 161 2009 443 449
77. D. Pasquali, M. Arcopinto, and A. Renzullo Cardiovascular abnormalities in Klinefelter Syndrome Int J Cardiol 168 2013 754 759
78. E. Giannetta, A.M. Isidori, and N. Galea Chronic inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging Circulation 125 2012 2323 2333
79. J. Buvat, M. Maggi, A. Guay, and L.O. Torres Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment J Sex Med 10 2013 245 284
80. Dohle GR, Arver S, Bettocchi S, Kliesch M, Punab M, de Ronde W. Guidelines on male hypogonadism. European Association of Urology Web site. http://www.uroweb.org/gls/pdf/16-Male-Hypogonadism-LR%20II.pdf. Updated 2012.
81. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559